definiens: shall mean data accessible throu gh Seller ’s Product regulatory safety database ( e.g ., the annual safety update reports provided by Seller to the FDA contained therein ) and the ARISg global saf ety database maintained by Seller, which data exists at the time such databases are transferred by Seller to Purchaser after the Closing and which may include, among othe r things, safety data generated by or for Seller or its Affiliates in the conduct of the clinical developme nt of Interferon Gamma-1b for the treatment of pati ents with idiopathic pulmonary fibrosis ; provided, however, t hat for purposes of clarity, IPF Patient Data shall not be deemed to include any case report forms, data ( othe r than the data accessible through Seller ’s regulat ory safety database and the ARISg global safety database descr ibed herein ), reports ( other than the annual safety update reports described herein ), publications, abstracts and other information, materials and patient sample s generated by or for Seller or its Affiliates in the conduct o f the clinical development of Interferon Gamma-1b f or the treatment of patients with idiopathic pulmonary fib rosis